Incyte (INCY) Operating Income (2009 - 2026)
Incyte (INCY) reported Operating Income of -$708.36 million for Q3 2026, compared with $443.52 million a year earlier.
Powered by 
Analysis
Incyte (INCY) Operating Income (2009 - 2026) Analysis & Trends
Over the twelve months ended Sep 30, 2026, Incyte's Operating Income came in at $626.51 million, down 57.7% year-over-year; for FY2025, it came in at $1.51 billion.
- By year, Operating Income came in at $61.37 million in FY2024 (-90.1%), $620.53 million in FY2023 (+7.1%), $579.44 million in FY2022 (-1.1%) and $585.78 million in FY2021.
- The Q3 2026 figure ranks as the lowest quarterly Operating Income in data going back to Q1 2010.
- The high point for year-over-year Operating Income in five years was Q1 2024 (growth of 271.0%); the low point was Q1 2023 (a decline of 78.7%).
- Per Business Quant data, the three quarters before Q3 2026 came in at $697.9 million (Q2 2026), $301.12 million (Q1 2026) and $335.86 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 8.41 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 6.18 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 6.27 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.56 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 4.39 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 3.71 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 3.46 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 5.47 Bn |
| 10 | Incyte | 245.42 Mn | -15.74 Bn | 1.45 Bn | -708.36 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -708.36 Mn |
| Jun 30, 2026 | 697.90 Mn |
| Mar 31, 2026 | 301.12 Mn |
| Dec 31, 2025 | 335.86 Mn |
| Sep 30, 2025 | 443.52 Mn |
| Jun 30, 2025 | 530.31 Mn |
| Mar 31, 2025 | 205.17 Mn |
| Dec 31, 2024 | 301.51 Mn |
| Sep 30, 2024 | 146.09 Mn |
| Jun 30, 2024 | -478.13 Mn |
| Mar 31, 2024 | 91.90 Mn |
| Dec 31, 2023 | 187.27 Mn |
| Sep 30, 2023 | 214.71 Mn |
| Jun 30, 2023 | 193.78 Mn |
| Mar 31, 2023 | 24.77 Mn |
| Dec 31, 2022 | 70.09 Mn |
| Sep 30, 2022 | 138.38 Mn |
| Jun 30, 2022 | 254.43 Mn |
| Mar 31, 2022 | 116.54 Mn |
| Dec 31, 2021 | 110.73 Mn |
API Access
Incyte Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-income&ticker=INCY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-income", "ticker": "INCY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-income&ticker=INCY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();